Assay Development

Assay Development refers to the process of designing and optimising analytical tests that measure product characteristics such as identity, purity, potency, and safety during biopharmaceutical development and manufacturing. Assays may include biochemical, immunological, cell-based, or molecular methods, each tailored to capture specific quality attributes relevant to the therapeutic modality. Effective assay development ensures that results are accurate, reproducible, and sensitive enough to detect meaningful changes in product quality or performance.

In the biopharmaceutical industry, assay development plays a critical role in enabling regulatory submissions, supporting comparability studies, and ensuring consistent manufacturing outcomes. Potency assays are especially important for biologics, as they reflect biological activity rather than simple chemical composition. Companies must develop assays that remain fit for purpose across different development stages, from early research to commercial release testing. As therapies become more complex, including gene therapies and multi-component biologics, assay development increasingly requires advanced analytical platforms, automation, and data integration strategies to support rapid decision making while maintaining rigorous quality standards.